• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将SαT段测量作为评估阿霉素诱导的大鼠心脏毒性最可靠的心电图参数。

Measurement of the S alpha T segment as the most reliable electrocardiogram parameter for the assessment of adriamycin-induced cardiotoxicity in the rat.

作者信息

Danesi R, Del Tacca M, Soldani G

出版信息

J Pharmacol Methods. 1986 Nov;16(3):251-9. doi: 10.1016/0160-5402(86)90046-x.

DOI:10.1016/0160-5402(86)90046-x
PMID:3784571
Abstract

A new method is described for the assessment of the early cardiotoxic effects of adriamycin and related drugs on rat electrocardiographic parameters. Evidence is presented that during repeated treatment with adriamycin, no changes occur concerning the PR and RR intervals, QTc, or R- and S-wave voltages, whereas significant changes in the QRS complex, R alpha T and alpha TP intervals, and T-wave voltage are detectable. However, the earliest and most consistent electrocardiogram alteration observed during adriamycin treatment is a progressive, irreversible widening of the S alpha T segment. The S alpha T enlargement becomes significant during the first week of treatment and may be detected in all the tracings at all the times examined. The electrocardiogram changes are accompanied by cardiac histological lesions that gradually increase in severity during the study. These results indicate that the measurement of the S alpha T segment provides a rapid, sensitive, and reliable method for the evaluation of electrocardiogram toxicity induced by adriamycin and related anthracyclines in the rat.

摘要

描述了一种评估阿霉素及相关药物对大鼠心电图参数早期心脏毒性作用的新方法。有证据表明,在反复使用阿霉素治疗期间,PR间期、RR间期、QTc或R波及S波电压无变化,而QRS波群、RαT和αTP间期以及T波电压有显著变化。然而,在阿霉素治疗期间观察到的最早且最一致的心电图改变是SαT段进行性、不可逆增宽。SαT增宽在治疗的第一周变得显著,并且在所有检查时间的所有描记图中均可检测到。心电图改变伴有心脏组织学损伤,在研究过程中其严重程度逐渐增加。这些结果表明,SαT段的测量为评估阿霉素及相关蒽环类药物在大鼠中引起的心电图毒性提供了一种快速、灵敏且可靠的方法。

相似文献

1
Measurement of the S alpha T segment as the most reliable electrocardiogram parameter for the assessment of adriamycin-induced cardiotoxicity in the rat.将SαT段测量作为评估阿霉素诱导的大鼠心脏毒性最可靠的心电图参数。
J Pharmacol Methods. 1986 Nov;16(3):251-9. doi: 10.1016/0160-5402(86)90046-x.
2
The influence of amrinone on cardiac toxicity induced by adriamycin in rats.氨力农对阿霉素诱导的大鼠心脏毒性的影响。
Arch Int Pharmacodyn Ther. 1986 Oct;283(2):243-53.
3
General and cardiac toxicity of adriamycinol in rats.阿霉素醇对大鼠的全身及心脏毒性
Anticancer Res. 1986 Sep-Oct;6(5):967-72.
4
Toxicologic screening of daunorubicin (NSC-82151), adriamycin (NSC-123127), and their derivatives in rats.
Cancer Chemother Rep. 1975 Jul-Aug;59(4):707-15.
5
Might adriamycinol contribute to adriamycin-induced cardiotoxicity?阿霉素醇会导致阿霉素引起的心脏毒性吗?
Pharmacol Res Commun. 1985 Nov;17(11):1073-84. doi: 10.1016/0031-6989(85)90113-4.
6
Toxicological evaluation of imipramine in combination with adriamycin and strophanthin.丙咪嗪与阿霉素及毒毛花苷K联合应用的毒理学评价
Agents Actions. 1977 Sep;7(3):341-6. doi: 10.1007/BF01969566.
7
Dissociation between in vitro cytotoxicity and in vivo cardiotoxicity of two new anthracyclines: 3'-deamino-3'-(2-methoxy-4-morpholinyl)doxorubicin and 4'-deoxy-4'-iodo-doxorubicin.
J Environ Pathol Toxicol Oncol. 1994;13(1):25-31.
8
Continuous electrocardiogram reveals differences in the short-term cardiotoxic response of Wistar-Kyoto and spontaneously hypertensive rats to doxorubicin.连续心电图显示Wistar-Kyoto大鼠和自发性高血压大鼠对阿霉素的短期心脏毒性反应存在差异。
Toxicol Sci. 2009 Jul;110(1):224-34. doi: 10.1093/toxsci/kfp092. Epub 2009 Apr 30.
9
Electrocardiographic and transmembrane potential effects of 5-iminodaunorubicin in the rat.5-亚氨基柔红霉素对大鼠心电图及跨膜电位的影响。
Cancer Res. 1984 Sep;44(9):4030-9.
10
Comparison of cardiotoxicity of pirarubicin, epirubicin and doxorubicin in the rat.吡柔比星、表柔比星和多柔比星对大鼠心脏毒性的比较。
Drugs Exp Clin Res. 1994;20(4):153-60.

引用本文的文献

1
Ameliorative effects and mechanism of crocetin in arsenic trioxide‑induced cardiotoxicity in rats.西红花酸对三氧化二砷诱导大鼠心脏毒性的改善作用及其机制。
Mol Med Rep. 2020 Dec;22(6):5271-5281. doi: 10.3892/mmr.2020.11587. Epub 2020 Oct 14.
2
Effect of fermented Cordyceps sinensis on doxorubicin‑induced cardiotoxicity in rats.发酵冬虫夏草对阿霉素致大鼠心脏毒性的影响。
Mol Med Rep. 2018 Sep;18(3):3229-3241. doi: 10.3892/mmr.2018.9310. Epub 2018 Jul 24.
3
Cardioprotective Effect of Grape Seed Extract on Chronic Doxorubicin-Induced Cardiac Toxicity in Wistar Rats.
葡萄籽提取物对多柔比星诱导的Wistar大鼠慢性心脏毒性的心脏保护作用
Adv Pharm Bull. 2016 Sep;6(3):423-433. doi: 10.15171/apb.2016.055. Epub 2016 Sep 25.
4
Chronic cardiotoxicity of anticancer anthracyclines in the rat: role of secondary metabolites and reduced toxicity by a novel anthracycline with impaired metabolite formation and reactivity.抗癌蒽环类药物对大鼠的慢性心脏毒性:次级代谢产物的作用以及一种代谢产物生成和反应性受损的新型蒽环类药物的毒性降低情况
Br J Pharmacol. 2003 Jun;139(3):641-51. doi: 10.1038/sj.bjp.0705270.
5
Fructose-1,6-diphosphate reduces acute ECG changes due to doxorubicin in isolated rat heart.果糖-1,6-二磷酸可减轻阿霉素所致离体大鼠心脏的急性心电图变化。
Experientia. 1988 Dec 1;44(11-12):1000-2. doi: 10.1007/BF01939901.
6
Protective effects of fructose-1,6-diphosphate on acute and chronic doxorubicin cardiotoxicity in rats.果糖-1,6-二磷酸对大鼠急性和慢性阿霉素心脏毒性的保护作用。
Cancer Chemother Pharmacol. 1990;25(5):326-32. doi: 10.1007/BF00686231.
7
Cardiac toxicity and antitumor activity of 4'-deoxy-4'-iodo-doxorubicinol.4'-脱氧-4'-碘阿霉素醇的心脏毒性和抗肿瘤活性
Cancer Chemother Pharmacol. 1990;26(6):403-8. doi: 10.1007/BF02994089.
8
Reducing doxorubicin cardiotoxicity in the rat using deferred treatment with ADR-529.
Cancer Chemother Pharmacol. 1992;30(2):95-9. doi: 10.1007/BF00686399.
9
Doxorubicin cardiotoxicity is associated with alterations of plasma levels of atrial natriuretic factor.阿霉素心脏毒性与心钠素血浆水平的改变有关。
J Endocrinol Invest. 1992 Feb;15(2):79-84. doi: 10.1007/BF03348668.
10
Reduced cardiotoxicity and increased cytotoxicity in a novel anthracycline analogue, 4'-amino-3'-hydroxy-doxorubicin.
Cancer Chemother Pharmacol. 1992;29(4):261-5. doi: 10.1007/BF00685942.